Applied DNA Sciences (NASDAQ:APDN) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Applied DNA Sciences (NASDAQ:APDN) in a report published on Thursday. The brokerage issued a hold rating on the technology company’s stock.

Separately, HC Wainwright increased their price target on shares of Applied DNA Sciences from $1.50 to $7.00 and gave the company a buy rating in a report on Monday, May 13th.

Applied DNA Sciences Trading Up 4.2 %

Shares of NASDAQ:APDN opened at $2.03 on Thursday. Applied DNA Sciences has a 12 month low of $1.65 and a 12 month high of $37.20. The company has a 50-day moving average price of $6.00 and a 200 day moving average price of $11.04. The company has a market cap of $2.00 million, a price-to-earnings ratio of -0.12 and a beta of 0.26.

Institutional Trading of Applied DNA Sciences

An institutional investor recently raised its position in Applied DNA Sciences stock. AMH Equity Ltd raised its position in Applied DNA Sciences, Inc. (NASDAQ:APDN) by 76.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 587,232 shares of the technology company’s stock after purchasing an additional 254,232 shares during the quarter. Applied DNA Sciences accounts for approximately 0.9% of AMH Equity Ltd’s holdings, making the stock its 18th biggest holding. AMH Equity Ltd owned approximately 4.30% of Applied DNA Sciences worth $711,000 at the end of the most recent quarter. 22.22% of the stock is owned by hedge funds and other institutional investors.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.